[BIIB] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[BIIB] Biogen Inc.
Announcement Date
13-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -61.89%
Quarter Report
BIIB's Result
BIIB's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 9,835,600 10,173,400 10,981,700 13,444,600 14,377,900 13,452,900 12,273,900 -3.62%
PBT 1,296,800 3,591,800 1,745,200 5,047,500 7,125,900 5,899,600 5,128,800 -20.47%
Tax 135,300 632,800 52,500 992,300 1,158,000 1,425,600 2,458,700 -38.31%
NP 1,161,100 3,046,900 1,556,100 4,000,600 5,888,500 4,430,700 2,539,100 -12.22%
Tax Rate -10.43% -17.62% -3.01% -19.66% -16.25% -24.16% -47.94% -
Total Cost 8,674,500 7,126,500 9,425,600 9,444,000 8,489,400 9,022,200 9,734,800 -1.90%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 11.81 29.95 14.17 29.76 40.96 32.93 20.69 -8.91%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 8.02 20.97 10.44 24.86 31.47 21.62 11.94 -6.41%
EPS Diluted 7.97 20.87 10.40 24.80 31.42 21.58 11.92 -6.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.